High expertise in the designing and testing of self-assembling peptides providing different benefits when culturing adherent cells in vitro.
CellulaREvolution has raised €2.1M across 1 funding round from 2 investors, most recently a round in Feb 2022. Based in Newcastle upon Tyne, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-18 | Other |
| €2.1M |
| Allusion One,Happiness Capital |
| View deal → |
